The mechanism of action of probiotics

Practical Gastroenterology

Volumn 29, Issue 5, 2005, Pages 29-47

  Michail, Sonia ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROBIOTIC AGENT; YOGHURT;

ALLERGIC REACTION; ANTIMICROBIAL ACTIVITY; BACTERIUM ADHERENCE; CANCER INHIBITION; CYTOKINE RELEASE; DRUG MECHANISM; GASTROINTESTINAL TRACT; HUMORAL IMMUNITY; IMMUNOMODULATION; LACTOBACILLUS; LACTOBACILLUS BULGARICUS; MICROFLORA; MILK; RESPIRATORY TRACT MUCOSA; REVIEW; UROGENITAL SYSTEM;

EID: 20444366125     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Metchnikoff E. Études sur la flore intestinale. Ann Inst Pasteur Paris, 1908;22:929-955.
2. Metchnikoff E. Études sur la flore intestinale-Deuxième mémoire. Ann Inst Pasteur Paris, 1910;24:755-770.
3. Sartor RB. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology, 2004;126:1620-1633.
4. Sartor RB. Microbial influences in inflammatory bowel disease: role in pathogenesis and clinical implications. In Kirsner's inflammatory bowel diseases, eds Sartor RB. Sandbom WJ. Edinburgh: Elsevier: 2003,138-162.
5. Chu FF, Esworthy RS, Chu PG, Longmate JA, Huycke MM, Wilczynski S, Doroshow JH. Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes. Cancer Res, 2004;64:962-968.
6. Kim DH, Jin YH. Intestinal bacterial beta-glucuronidase activity of patients with colon cancer. Arch Pharm Res, 2001;24:564-567.
7. Morotomi M, Kado S. Intestinal microflora and cancer prevention. Can To Kagaku Ryoho, 2003;30:741-747.
8. Balsari A, Ceccarelli A, Dubini F, Fesce E, Poli G. The fecal microbial population in the irritable bowel syndrome. Microbiology, 1982;5:185-194.
9. King TS, Elia M, Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet, 1998;352:1187-1189.
10. Watanabe S, Narisawa Y, Arase S, Okamatsu H, Ikenaga T, Tajiri Y, Kumemura M. Differences in fecal microflora between patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol, 2003;111:587-591.
11. Jijon H, Backer J, Diaz H, Yeung H, Thiel D, McKaigney C, De Simone C, Madsen K. DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology, 2004;126:1358-1373.
12. Yan F, Polk DB. Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Biochem, 2002;277:50959-50965.
13. Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, Rudensky B, Akira S, Takeda K, Lee J, Takabayashi K, Raz E. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology, 2004;126:520-528.
14. Westendorf AM, Gunzer F, Deppenmeier S, Tapadar D, Hunger JK, Schmidt MA, Buer J, Bruder D. Intestinal immunity of Escherichia coli NISSLE 1917: a safe carrier for therapeutic molecules. FEMS Immunol Med Microbiol, 2005;43:373-384.
15. Ibnou-Zekri N, Blum S, Schiffrin EJ, et al: Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect Immun, 2003;71:428-436.
16. Wollowski I, Rechkemmer G, Pool-Zobel BL. Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr, 2001;73:451S-455S.
17. Shi HN, Walker A. Bacterial colonization and the development of intestinal defenses. Can J Gastroenterol, 2004;18:493-500.
18. Agarwal R, Sharma N, Chaudhry R, et al: Effects of oral Lactobacillus GG on enteric microflora in low-birth-weight neonates. J Pediatr Gastroenterol Nutr, 2003;36:397-402.
19. Vandenbergh PA. Lactic acid bacteria, their metabolic products and interference with microbial growth. FEMS Microbiol Rev. 1993;12:221-238.
20. Rossland E, Langsrud T, Granum PE, Sorhaug T. Production of antimicrobial metabolites by strains of Lactobacillus or Lactococcus co-cultured with Bacillus cereus in milk. Int J Food Microbiol, 2005;1;98(2):193-200.
21. Cadieux P, Burton J, Gardiner G, Braunstein I, Bruce AW, Kang CY, Reid G. Lactobacillus strains and vaginal ecology. JAMA, 2002;287:1940-1941.
22. Silva M, Jacobus NV, Deneke C, Gorbach SL. Antimicrobial substance from a human Lactobacillus strain. Antimicrob Agents Chemother, 1987;31:1231-1233.
23. Meurman JH, Antila H, Korhonen A, Salminen S. Effect of Laclobacillus rhamnosus strain GG (ATCC 51303) on the growth of Streptococcus dobrinus in vitro. Eur J Oral Sci, 1995;103:253-258.
24. Bernet-Camard MF, Lievin V, Brassart D, Neeser JR, Servin AL, Hudault S. The human Lactobacillus acidophilus strain LA1 secretes a non-bacteriocin antibacterial substance(s) active in vitro and in vivo. Appl Environ Microbiol, 1997;63:2747-2753.
25. Lievin V, Peiffer I, Hudault S, Rochat F, Brassart D, Neeser JR, Servin AL. Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity. Gut, 2000;47:646-652.
26. Alander M, Korpela R, Saxelin M, Vilponnen-Salmela T, Mattila-Sandholm T, vonWright A. Recovery of Lactobacillus rhamnosus, GG from human colonic biopsies. Lett Appl Microbiol, 1997;24:361-364.
27. Kleeman EG, Klaenhammer TR. Adherence of Lactobacillus species to human fetal intestinal cells. J Dairy Sci, 1982;65:2063-2069.
28. Conway PL, Goldin BR, Gorbach SL. Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J Dairy Sci, 1987;70:1-12.
29. Goldin BR, Gorbach SL, Saxelin M, Barakat S, Gualtieri L, Salminen S. Survival of Lactobacillus, species (Strain GG) in human gastrointestinal tract. Dig Dis Sci, 1992;37:121-128.
30. Mack DR, Michail S, Wei S, Macdougal L, Hollingsworth MA. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol, 1999;39:G941-G950.
31. Davidson JN, Hirsch DC. Bacterial competition as a means of preventing diarrhea in pigs. Infect Immun, 1976;13:1773-1774.
32. Rigothier MC, Maccanio J, Gayral P. Inhibitory activity of Saccharomyces yeasts on the adhesion of Entamoeba histolytica trophozoites to human erythrocytes in vitro. Parasitol Res, 1994;80:10-15.
33. Bernet MF, Brassart D, Neeser JR, Servin AL. Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut, 1994 35:483-489.
34. Wilson KH, Perini I. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect Immun, 1988;56:2610-2614.
35. Pothoulakis C, Kelly CP, Joshi MA, et al. Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. Gastroenterology, 1993;104:1108-1115.
36. Cebra JJ. Influences of microbiota on intestinal immune system development. Am J Clin Nutr, 1999;69:1046S-1051S.
37. Resta-Lenert S, Barrett KE: Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut, 2003;52:988-997.
38. Guarner F, Garcia-Lafuente A, Antolin M, Malagelada JR. Intestinal permeability and microflora. Publication Symposium on Fermented Food, Fermentation and Intestinal Flora, 1998.
39. Michail S, Abernathy F. Lactobacillus plantarum inhibits the intestinal transepithelial migration of neutrophils induced by enteropathogenic Escherichia coli. J Pediatr Gastroenterol Nutr, 2003;36:385-391.
40. Michail S, Abernathy F. Lactobacillus plantarum reduces the in vitro secretory response of intestinal epithelial cells to Enteropathogenic Escherichia Coli infection. J Pediatr Gastroenterol Nutr, 2002;35:350-355.
41. Jahn HU, Ullrich R, Schneider T, Liehr RM, Schieferdecker HL, Holst H, Zeitz M. Immunological and trophical effects of Saccharomyces boulardii on the small intestine in healthy human volunteers. Digestion, 1996;57:95-104.
42. Buts JP, deKeyser N, deRaedemaekier L. Saccharomyces boulardii enhances rat intestinal enzyme expression by endoluminal release of polyamines. Pediatr Res, 1994;36:522-527.
43. Steidler L, Hans W, Schotte L, Neirynck S, Obermeier F, Falk W, et al. Treatment of murine colitis by Lactobacillus lactis secreting interleukin-10. Science, 2000;289:1352-1355.
44. Dahan S, Dalmasso G, Imbert V, Peyron JF, Rampal P, Czerucka D. Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells. Infect Immun, 2003;71:766-773.
45. Petrof EO, Kojima K, Ropeleski MJ, Musch MW, Tao Y, De Simone C, Chang EB. Probiotics inhibit nuclear factor-kappa B and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology, 2004;127:1474-1487.
46. Kaila M, Isolauri E, Saxelin M, Arvilommi H, Vesikari T. Viable versus inactivated lactobacillus strain GG in acute rotavirus diarrhoea. Arch Dis Child, 1995;72:51-53.
47. Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr Res, 1992;32:141-144.
48. de Vrese M, Rautenberg P, Laue C, Koopmans M, Herremans T, Schrezenmeir J. Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination. Eur J Nutr, 2004 Dec 1; (pubmed ahead of print, March 2005).
49. Park JH, Um JI, Lee BJ, Goh JS, Park SY, Kim WS, Kim PH. Encapsulated Bifidobacterium bifidum potentiates intestinal IgA production. Cell Immunol, 2002;219:22-27.
50. Buts JP, Bernasconi P, Vaerman JP, Dive C. Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii. Dig Dis Sci, 1990;35:251-256.
51. Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol, 2002;168:171-178.
52. Di Giacinto C, Marinaro M, Sanchez M, Strober W, Boirivant M. J Immunol, 2005;15;174:3237-3246.
53. Parra MD, Martinez de Morentin BE, Cobo JM, Mateos A, Martinez JA. Daily ingestion of fermented milk containing Lactobacillus casei DN114001 improves innate-defense capacity in healthy middle-aged people. J Physiol Biochem, 2004;60:85-91.
54. Pelto L, Isolauri E, Lilius EM, Nuutila J, Salminen S. Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clin Exp Allergy, 1998;28:1474-1479.
55. Wehkamp J, Harder J, Wehkamp K, Wehkamp-von Meissner B, Schlee M, Enders C, Sonnenborn U, Nuding S, Bengmark S, Fellermann K, Schroder JM, Stange EF. NF-kappaB- and AP-1-mediated induction of human beta defensin-2 in intestinal epithelial cells by Escherichia coli Nissle 1917: a novel effect of a probiotic bacterium. Infect Immun, 2004;72:5750-5758.
56. Buts JP, Bernasconi P, Van Craynest MP, Maldaque P, deMeyer R. Response of human and rat small intestinal mucosa to oral administration of Saccharomyces boulardii. Pediatr Res, 1986;20:192-196.
57. Kalliomaki MA, Isolauri E. Probiotics and down-regulation of the allergic response. Immunolgy Allergy Clin North Am, 2004;24;739-752.
58. Viljanen M, Savilahti E, Haahtela T, Juntunen-backman K, Korpela R, Poussa T, Tuure T, Kuitunen M. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy, 2005, 60:494-500.
59. Pouchard P, Gosset P, Grangette C, Andre C, Tonnel AB, Pestel J, Mercenier A. Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients. J Allergy Clin Immunol, 2002;110:617-623.
60. Rosenfeldt V, Benfeldt E, Valerius NH, Paerregaard A, Michaelsen KF. Effect of probiotics on gastrointestinal symptoms and small intestinal permeability in children with atopic dermatitis. J Pediatr, 2004;145:612-616.
61. Mastrandrea F, Coradduzza G, Sero G, Minardi A, Manelli M, Ardito S, Muratire L. Probiotics reduce the CD34+ hemopoietic precursor cell increased traffic in allergic subjects. Allerg Immunol, 2004;36:118-122.
62. Pohjavuori E, Viljanen M, Korpela R, Kiutunen M, Tittanen M, Vaarala O, Savilahti E. Lactobacillus GG effect in increasing IFN-gamma production in infants with cow's milk allergy. J Allergy Clin Immunol, 2004;114:131-136.
63. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomized placebo-controlled trial. Lancet, 2003, 361:1869-1871.
64. Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr, 2003;36:223-227.
65. Rosenfeldt V, Benfeldt E, Nielsen SD, et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol, 2003, 111:389-395.
66. Kalliomaki MA, Isolauri E. Probiotics and down-regulation of the allergic response. Immunol Allergy Clin North Am, 2004;24:739-752.
67. Tagg JR, Dierksen KP. Bacterial replacement therapy: adapting "germ warfare" to infection prevention. Trends Biotechnol, 2003;21:217-223.
68. Golledge CL, Riley TV. "Natural" therapies for infectious diseases. Med J Aust, 1996;164:94-95.
69. Hatakka K, Savilahti E, Ponka A, Meurman JH, Poussa T, Nase L, et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomized trial. BMJ, 2001;322;1327-1331.
70. Lee JW, Shin JG, Kim EH, Kang HE, Yim IB, Kim JY, Joo HG, Woo HJ. Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. J Vet Sci, 2004;5:41-48.
71. Marotta F, Naito Y, Minelli E, Tajiri H, Bertuccelli J, Wu CC, Min CH, Hotten P, Fesce E. Chemopreventive effect of a probiotic preparation on the development of preneoplastic and neoplastic colonic lesions: an experimental study. Hepatogastroenterology, 2003;50(54):1914-1918.
72. Saikali J, Picard C, Freitas M, Holt P. Fermented milks, probiotic cultures, and colon cancer. Nutr Cancer, 2004;49:14-24.